Eastman Chemical Director Acquires $54k in Stock Units (EMN)
EASTMAN CHEMICAL CO
Subscribe to track EMN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Eastman Chemical Director Acquires $54k in Stock Units (EMN)
Company: EASTMAN CHEMICAL CO (EMN) Form: 4 | Filed: 2025-10-09 Significance: Low
Insider: Audia Damon J Title: null | Relationship: Director
Transaction: • Type: Acquisition (Compensation) • Shares: 1,360 Phantom Stock Units • Avg Price: $40.02 • Value: $54,432 • Owned After: 1,360 units
Key Insight: A director acquired phantom stock units by deferring director's fees, as part of a compensation plan. This is not an open-market purchase and has low signaling value.
Market Context: This is a routine compensation-related transaction, reflecting an alignment of interest rather than a new investment decision based on market conditions.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: EASTMAN CHEMICAL CO (EMN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director, Damon J. Audia, acquired 1,360 Phantom Stock Units valued at approximately $54,432 as part of a director compensation plan. This is not an open-market purchase and carries minimal predictive value.
- Market Impact: The transaction is unlikely to have a significant impact on the stock price as it is a routine compensation-related event, not a discretionary insider buy.
Company Information
| Field | Value |
|---|---|
| Company | EASTMAN CHEMICAL CO |
| Ticker Symbol | EMN |
| CIK | 0000915389 |
| Industry | Plastics, Materials, Synth Resins & Nonvulcan Elastomers |
Insider Information
| Field | Value |
|---|---|
| Name | Audia Damon J |
| CIK | 0001452301 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
This filing reports two related acquisitions of Phantom Stock Units on the same day, which are aggregated here for clarity.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-07 |
| Transaction Code | A (Acquisition, not an open market purchase) |
| Security Type | Phantom Stock Units |
| Shares Involved | 1,360 |
| Price Per Share | $40.02 (Weighted Average) |
| Total Value | $54,431.55 |
| Shares Owned After | 1,360 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The acquisition is a result of deferring director's fees into stock units, as specified in the company's compensation plan. Such transactions are common and do not reflect new, market-driven investment decisions by the insider. Therefore, the market is not expected to react to this filing.
Volume & Sentiment
- Expected Volume Impact: Negligible. This is a non-market transaction and will not affect trading volume.
- Sentiment Indicator: Neutral. While an acquisition is technically bullish, the context of it being deferred compensation negates any strong sentiment shift.
Investment Insights
Positive Market Indicators
- An insider choosing to receive compensation in stock-equivalent units demonstrates a long-term alignment with shareholder interests.
Risk Factors
- This transaction provides no new information about the company's near-term prospects.
Key Takeaways
- Compensation, Not Investment: The core of this transaction is the deferral of director's fees into Phantom Stock Units, not a discretionary purchase with personal capital.
- Phantom Stock Units: These are not common stock. As noted in the filing's footnotes, they are payable only in cash after the director's service terminates, with a value tied to the common stock price.
- Low Signaling Value: Due to the non-discretionary and compensatory nature of the acquisition, it should not be interpreted as a bullish signal based on insider knowledge.
Contextual Analysis
Timing Significance
- The transaction date aligns with a typical compensation schedule and does not appear to be timed in relation to any specific market event or non-public information.
Transaction Context
- Footnotes F1, F2, and F3 clearly state the nature of the transaction. The units were credited under the Directors' Deferred Compensation Plan through both voluntary and automatic deferrals of retainer fees. This is a standard practice for director compensation.
Company Context
- This analysis is based solely on the filing. A full picture would require reviewing Eastman Chemical's recent performance, earnings reports, and any industry news affecting the chemical sector.
Risk Assessment
Risk Level: Low
Risk Factors
- Misinterpretation: The primary risk is an investor misinterpreting this as a bullish open-market purchase, which it is not.
- No New Information: The filing does not provide any new fundamental insights into the company's health or future performance.
Market Considerations
- Investors should focus on fundamental analysis, earnings reports, and industry trends for Eastman Chemical rather than drawing conclusions from this routine insider filing.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-09 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.